🇺🇸 FDA
Patent

US 6825190

Protein kinase inhibitors and uses thereof

expired A61PA61P1/16A61P11/06

Quick answer

US patent 6825190 (Protein kinase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/16, A61P11/06, A61P19/02, A61P21/00